- Author, “Biosimilars Now Just About Ready to Roll,” Genetic Engineering & Biotechnology News, September 1, 2012
- Author, “Claim Construction Strategies for Trial and Appeal in Pharma Litigation,” Corporate Counsel Magazine, August 15, 2012
- Quoted, “New Laws of Nature Law: Ruling Questions Scientific Patents,” ABA Journal, July 1, 2012
- Author, “Addressing Breach of Method-of-Use Patents by Generics,” Law360, May 2, 2012
- Author, “Federal Circuit Addresses Infringement of Method-of-Use Patents by Generics in Yasmin® Case,” Duane Morris Alert, April 18, 2012
- Author, “A Proposal to Curb Misuse of ‘Exceptional Case’ Allegations Against ANDA Applicants,” GenericsWeb INNsight, June 2010
- Author, “Takeda V. Mylan — Keeping Your Ducks In A Row,” Law 360, January 13, 2009
- Author, “Obviousness of Chemical Compounds: The Lead Compound Concept,” Intellectual Property Today, July 2007
- Author, “Cannabis Patent Review II: Patented (and Unapproved) Therapeutic Uses for CBD,” Duane Morris LLP (Linked-In), February 12, 2020
- Author, “Cannabis Patent Review I: Extraction and Purification,” Duane Morris LLP (Linked-In), December 5, 2019
- Speaker, “Blunt Talk About Cannabis Patents,” ACS National Meeting and Expo, San Diego, August 26, 2019
- Quoted, “How much pot in that brownie? Chocolate can throw off tests,” AP News, August 26, 2019
- Quoted, “Making Your Mark and Protecting It,” Marijuana Business Magazine, July 2019
- Author, “Navigating the Cannabis Patent Landscape,” Corporate Counsel, July 1, 2019
- Presenter, “Cannabis 202: IP Issues Facing the Cannabis Industry,” Duane Morris Cannabis Webinar Series, June 18, 2019
- Quoted, “Pending Case, Cannabis Companies May Be Able to Prosecute Patent Infringements in Court,” Corporate Counsel, May 21, 2019
- Quoted, “Colo. Ruling Could Provide Road Map For Cannabis Inventors,” Law360, April 26, 2019
- Author, “UCANN’s Liquid Cannabis Patent Survives Section 101 Challenge by Pure Hemp; Judge Questions Novelty, Usefulness and Nonobviousness,” Duane Morris Alert, April 22, 2019
- Author, “Is New Hampshire the Next State to Legalize Cannabis?,” Duane Morris Alert, February 4, 2019
- Author, “Can You Patent a Bong Made Out of an Apple?” Duane Morris LLP (Linked-In), January 7, 2019
Speaking Engagements (Pharma and Biotech)
- “Pharmaceutical Patent Invalidity Challenge Score Card: District Courts v. The PTAB,” ACI’s Paragraph IV Disputes Conference, New York, April 2016
- “Legal & Regulatory Implications of ‘Similarity’ and ‘Interchangeability,'” Biosimilars Clinical Studies & Analytical Similarity Summit, Boston, March 2016
- “Update from the U.S.: Regulatory Exclusivities, Biosimilars Progress and New Court Decisions,” World Generic Medicines Congress, Barcelona, Spain, April 3, 2014
- “Latest Developments in Pharma/Life Sciences Patent Litigation,” Fordham University School of Law IP Summit, New York, November 2013
- “Understanding the Nuts and Bolts of Biosimilar Regulatory Requirements,” 14th Annual Business of Biosimilars Conference, Boston, October 15, 2013
- “Litigation Management Strategy Discussion,” Momentum’s International Congress on Paragraph IV Litigation, New York, September 2013
- Speaker, “Third Party IP: Preserving Freedom to Operate,” FDLI’s conference on IP Throughout the Drug Development Lifecycle, Washington D.C., July 2012
- “New Standards in Inequitable Conduct Post-Therasense: Ethical Considerations for Paragraph IV Cases,” ACI Conference on Paragraph IV Disputes, New York, April 2012
- “Successfully Navigating Claim Construction in Life Sciences Litigation,” IProperty Owners Association Chat Channel webinar on current topics in IP, January 2012
- “New Standards and Controversies in Double Patenting Type Obviousness,” ACI Conference on Paragraph IV Disputes, May 2011
- “Double Patenting: A Newly Vigorous Defense in Patent Litigation,” Intellectual Property Owners Association Chat Channel webinar on current topics in IP, February 2011
- “Litigating with Multiple ANDA Filers: Brand Name and Generic Perspectives,” ACI Conference on Paragraph IV Disputes, San Francisco, December 2010
- “Pre-Litigation Strategy, Analysis and Preparation for PIV Disputes,” CBI’s 3rd Annual Life Sciences Congress on Paragraph IV Disputes, Alexandria, Virginia, October 2010
- “Biosimilars and Follow-On Biologics,” Licensing Executives Society, Chicago, May 2008
Scientific Publications
- JL Sessler, VL Capuano and A Harriman, “Electronic Energy Migration and Trapping in Quinone-Substituted, Phenyl-Linked Dimeric and Trimeric Porphyrins,” J. Am. Chem. Soc., 115(11): 4618-4628 (1993);
- JL Sessler, VL Capuano and AK Burrell, “Orthogonal RuII(bpy)3 Complexes in Meso-Substituted Porphyrins,” Inorganica Chimica Acta, 204(1): 93-101 (1993);
- JL Sessler and VL Capuano, “Selective Insertion of Ni(II) into the Outer Porphyrin Subunits of a Trimeric Porphyrin Array,” Tetrahedron Letters, 34(14): 2287-2290 (1993);
- JL Sessler, VL Capuano, Y Kubota, MR Johnson, D Magda and AH Harriman, “Examining Long-Distance Electron Transfer with Synthetic Model Systems,” in Photoprocesses in Transition Metal Complexes, Biosystems and Other Molecules. Experiment and Theory, 375-401 (1992);
- JL Sessler and VL Capuano, “Phenyl-Linked Quinone-Substituted Porphyrin Trimers,” Angewandte Chemie, 102(10): 1162-1164 (1990); Int. Ed. Engl., 29(10): 1134-1137 (1990);
Doctoral Dissertation
- “Porphyrin-Mediated Electron Transfer,” University of Texas at Austin, Austin, TX, December 1991;